University of Leicester
Browse
dgac384.pdf (220.99 kB)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions

Download (220.99 kB)
journal contribution
posted on 2022-08-05, 09:23 authored by Francesco Zaccardi, Kamlesh Khunti

Over the course of the COVID-19 pandemic, epidemiological investigations have explored the risk of various medical conditions following the acute phase of the COVID-19 infection. Although variable definitions and terms have been proposed, this cluster of conditions—encompassing mental health, neurological, metabolic, cardiorespiratory, gastrointestinal, musculoskeletal, coagulative, renal, and dermatological disorders—is commonly referred to as “post-acute sequelae of SARS-CoV-2 infection” or “long-COVID” syndrome (1). 

Funding

National Institute for Health Research (NIHR) – Applied Research Collaboration (ARC) East Midlands

History

Author affiliation

Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester

Version

  • VoR (Version of Record)

Published in

The Journal of Clinical Endocrinology & Metabolism

Publisher

Oxford University Press for Endocrine Society

issn

0021-972X

eissn

1945-7197

Acceptance date

2022-06-21

Copyright date

2022

Available date

2022-08-05

Spatial coverage

United States

Language

English

Usage metrics

    University of Leicester Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC